메뉴 건너뛰기
Infectious Diseases in Clinical Practice
Volumn 20, Issue 2, 2012, Pages 157-160
Novel therapeutic combinations for methicillin-resistant staphylococcus aureus bacteremia and prosthetic joint infection with evolving multidrug resistance
Author keywords

bacteremia; daptomycin oxacillin combination; methicillin resistant Staphylococcus aureus; septic arthritis; systemic and in situ antibiotics
Indexed keywords

DAPTOMYCIN; DIPHENHYDRAMINE; LINEZOLID; METHYLPREDNISOLONE; OXACILLIN; RIFAMPICIN; VANCOMYCIN;
EID: 84858860152     PISSN: 10569103     EISSN: 15369943     Source Type: Journal    
DOI: 10.1097/IPC.0b013e31822e9bcd     Document Type: Article
Times cited : (2)
References (16)
  • 1
    • 77957759717 scopus 로고    scopus 로고
    • Why has methicillin-resistant Staphylococcus aureus become such a successful pathogen in adults?
    • Moellering RC. Why has methicillin-resistant Staphylococcus aureus become such a successful pathogen in adults? Infect Dis Clin Pract. 2010;18:286-291.
    • (2010) Infect Dis Clin Pract. , vol.18 , pp. 286-291
    • Moellering, R.C.1
  • 3
    • 0029844946 scopus 로고    scopus 로고
    • Antibiotic-impregnated cement and beads for orthopedic infections
    • Wininger DA, Fass RJ. Antibiotic-impregnated cement and beads for orthopedic infections. Antimicrob Agents Chemother. 1996;40:2675-2679.
    • (1996) Antimicrob Agents Chemother. , vol.40 , pp. 2675-2679
    • Wininger, D.A.1    Fass, R.J.2
  • 4
    • 77954740505 scopus 로고    scopus 로고
    • An approach for determining antibiotic loading for a physician-directed antibiotic-loaded PMMA bone cement formulation
    • Lewis G, Brooks JL, Courtney HS, et al. An approach for determining antibiotic loading for a physician-directed antibiotic-loaded PMMA bone cement formulation. Clin Orthop Relat Res. 2010;468:2092-2100.
    • (2010) Clin Orthop Relat Res. , vol.468 , pp. 2092-2100
    • Lewis, G.1    Brooks, J.L.2    Courtney, H.S.3
  • 5
    • 59749097857 scopus 로고    scopus 로고
    • Optimized elution of daptomycin from polmethylmethacrylate beads
    • Weiss BD, Weiss EC, Haggard WO, et al. Optimized elution of daptomycin from polmethylmethacrylate beads. Antimicrob Agents Chemother. 2009;53:264-266.
    • (2009) Antimicrob Agents Chemother. , vol.53 , pp. 264-266
    • Weiss, B.D.1    Weiss, E.C.2    Haggard, W.O.3
  • 6
    • 9944223765 scopus 로고    scopus 로고
    • Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber
    • Hall WE, Rouse MS, Jacofsky DJ, et al. Release of daptomycin from polymethylmethacrylate beads in a continuous flow chamber. Diagn Microbiol Infect Dis. 2004;50:261-265.
    • (2004) Diagn Microbiol Infect Dis. , vol.50 , pp. 261-265
    • Hall, W.E.1    Rouse, M.S.2    Jacofsky, D.J.3
  • 7
    • 0026350645 scopus 로고
    • Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement
    • Kuechle DK, Landon GC, Musher DM, et al. Elution of vancomycin, daptomycin, and amikacin from acrylic bone cement. Clin Orthop. 1991;264:302-308.
    • (1991) Clin Orthop. , vol.264 , pp. 302-308
    • Kuechle, D.K.1    Landon, G.C.2    Musher, D.M.3
  • 8
    • 31544451594 scopus 로고    scopus 로고
    • Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis
    • Rouse MS, Piper KE, Jacobson M, et al. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. J Antimicrob Chemother. 2006;57:301-305.
    • (2006) J Antimicrob Chemother. , vol.57 , pp. 301-305
    • Rouse, M.S.1    Piper, K.E.2    Jacobson, M.3
  • 9
    • 42049110559 scopus 로고    scopus 로고
    • Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection
    • Moise PA, Castro RS, Sul C, et al. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection. Ann Pharmacother. 2008;42:592-593.
    • (2008) Ann Pharmacother. , vol.42 , pp. 592-593
    • Moise, P.A.1    Castro, R.S.2    Sul, C.3
  • 10
    • 44049103101 scopus 로고    scopus 로고
    • High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia
    • Sharma M, Riederer K, Chase P, et al. High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2008;27:433-437.
    • (2008) Eur J Clin Microbiol Infect Dis. , vol.27 , pp. 433-437
    • Sharma, M.1    Riederer, K.2    Chase, P.3
  • 11
    • 70349173209 scopus 로고    scopus 로고
    • Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: Facts and assumptions
    • Moise PA, North D, Steenbergen JN, et al. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: Facts and assumptions. Lancet Infect Dis. 2009;9:617-624.
    • (2009) Lancet Infect Dis. , vol.9 , pp. 617-624
    • Moise, P.A.1    North, D.2    Steenbergen, J.N.3
  • 12
    • 33747365321 scopus 로고    scopus 로고
    • Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    • Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355:653-665.
    • (2006) N Engl J Med. , vol.355 , pp. 653-665
    • Fowler Jr., V.G.1    Boucher, H.W.2    Corey, G.R.3
  • 13
    • 3342957138 scopus 로고    scopus 로고
    • Synergy of daptomycin with oxacillin and other A-lactams against methicillin-resistant Staphylococcus aureus
    • Rand KH, Houck HJ. Synergy of daptomycin with oxacillin and other A-lactams against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:2871-2875.
    • (2004) Antimicrob Agents Chemother. , vol.48 , pp. 2871-2875
    • Rand, K.H.1    Houck, H.J.2
  • 14
    • 77955374467 scopus 로고    scopus 로고
    • Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin- resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect")
    • Yang SJ, Xiong YQ, Boyle-Vavra S, et al. Daptomycin-oxacillin combinations in treatment of experimental endocarditis caused by daptomycin-nonsusceptible strains of methicillin-resistant Staphylococcus aureus with evolving oxacillin susceptibility (the "seesaw effect"). Antimicrob Agents Chemother. 2010;54:3161-3169.
    • (2010) Antimicrob Agents Chemother. , vol.54 , pp. 3161-3169
    • Yang, S.J.1    Xiong, Y.Q.2    Boyle-Vavra, S.3
  • 15
    • 77950355815 scopus 로고    scopus 로고
    • Supplemental A-lactam rescue in clearance of bacteremia due to MRSA with reduced vancomycin and daptomycin susceptibility
    • San Francisco, CA. Washington, DC: American Society for Microbiology; Abstract C2-42
    • Dhand A, Wang G, Nizet V, et al. Supplemental A-lactam rescue in clearance of bacteremia due to MRSA with reduced vancomycin and daptomycin susceptibility. In: Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA. Washington, DC: American Society for Microbiology; 2009. Abstract C2-42.
    • (2009) Abstracts of the Forty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy
    • Dhand, A.1    Wang, G.2    Nizet, V.3
  • 16
    • 15844380990 scopus 로고    scopus 로고
    • In vivo synergy of daptomycin plus a penicillin agent for MRSA?
    • Scheetz M, Reddy P, Postelnic M, et al. In vivo synergy of daptomycin plus a penicillin agent for MRSA? J Antimicrob Chemother. 2005;55:398-399.
    • (2005) J Antimicrob Chemother. , vol.55 , pp. 398-399
    • Scheetz, M.1    Reddy, P.2    Postelnic, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.